The effect of short-chain fatty acids on human monocyte-derived dendritic cells.
Nastasi C, Candela M, Bonefeld CM, Geisler C, Hansen M, Krejsgaard T, Biagi E, Andersen MH, Brigidi P, Ødum N, Litman T, Woetmann A. · 2015
Read The effect of short-chain fatty acids on human monocyte-derived dendritic cells. by Nastasi C, Candela M, Bonefeld CM, Geisler C, Hansen M, Krejsgaard T, Biagi E, Andersen MH, Brigidi P, Ødum N, Litman T, Woetmann A. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4635422.txt.
Introduction
In 2015, Claudia Nastasi and colleagues published a study on how short-chain fatty acids, made by gut bacteria, affect human dendritic cells. These immune cells sample threats and direct responses. Acetate, butyrate, and propionate are the main fatty acids from fibre fermentation. The team exposed lab-grown dendritic cells to each one. The work appeared in Scientific Reports.
Acetate changed little, but butyrate and propionate strongly reprogrammed gene activity, especially in mature cells. Both cut the release of several inflammation-recruiting signals and blocked production of inflammatory cytokines such as IL-6. Pathway analysis pointed to reduced white blood cell trafficking. The findings show that bacterial products made in the gut can tune immune behaviour far from where they are produced, with a broadly calming effect.
Catalog record
| CREATOR | Nastasi C, Candela M, Bonefeld CM, Geisler C, Hansen M, Krejsgaard T, Biagi E, Andersen MH, Brigidi P, Ødum N, Litman T, Woetmann A. |
|---|---|
| YEAR | 2015 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
The effect of short-chain fatty acids on human monocyte-derived dendritic cells By Claudia Nastasi, Marco Candela, Charlotte Menné Bonefeld, Carsten Geisler, Morten Hansen, Thorbjørn Krejsgaard, Elena Biagi, Mads Hald Andersen, Patrizia Brigidi, Niels Ødum, Thomas Litman, Anders Woetmann Published in: Scientific Reports DOI: 10.1038/srep16148 ABSTRACT Abstract The gut microbiota is essential for human health and plays an important role in the pathogenesis of several diseases. Short-chain fatty acids (SCFA), such as acetate, butyrate and propionate, are end-products of microbial fermentation of macronutrients that distribute systemically via the blood. The aim of this study was to investigate the transcriptional response of immature and LPS-matured human monocyte-derived DC to SCFA. Our data revealed distinct effects exerted by each individual SCFA on gene expression in human monocyte-derived DC, especially in the mature ones. Acetate only exerted negligible effects, while both butyrate and propionate strongly modulated gene expression in both immature and mature human monocyte-derived DC. An Ingenuity pathway analysis based on the differentially expressed genes suggested that propionate and butyrate modulate leukocyte trafficking, as SCFA strongly reduced the release of several pro-inflammatory chemokines including CCL3, CCL4, CCL5, CXCL9, CXCL10, and CXCL11. Additionally, butyrate and propionate inhibited the expression of lipopolysaccharide (LPS)-induced cytokines such as IL-6 and IL-12p40 showing a strong anti-inflammatory effect. This work illustrates that bacterial metabolites far from the site of their production can differentially modulate the inflammatory response and generally provides new insights into host-microbiome interactions. The gut microbiota is essential for several aspects of human health and is involved in the pathogenesis or as protection factor for several human diseases, such as obesity, inflammatory bowel disease, type 1–2 diabetes, atopic disease, acute graft-versus host disease1,2,3,4. Recent studies highlight the profound effect of fiber-rich diet on the metabolism and composition of the gut microbiota, with profound feedback consequences on the host immunological pathways5,6. However, most of the mechanisms of host-microbiota interactions remain obscure. Dietary fibers have been linked with a lower risk of death from a range of conditions, including cardiovascular disease, infections and cancers7. It seems clear that making fiber-rich food choices more often may provide significant health benefits but, however, little is known about the mechanisms. Dietary fibers are complex carbohydrates that can be fermented by fibrolythic components of the gut microbiota, generating physiologically active metabolites. Short-chain fatty acids (SCFA), such as acetate, butyrate and propionate, are among the most abundant of these dietary metabolites released in the proximal colon at high concentrations (70–140 mM) while lower concentrations are found in the distal colon (20–70 mM) and in the distal ileum (20–40 mM). The molar ratio of acetate, propionate, and butyrate production in the colon is approximately 60:25:15, respectively, but it varies depending on diet, site of fermentation, and microbiota composition8,9. Notably, SCFA are not restricted to the intestinal lumen but are readily absorbed by colonocytes, released into the bloodstream and then reach the liver through the portal vein. From here SCFA are then released systematically to the peripheral venous system at even lower concentrations10. Experiments carried out on mice models allowed dissection of the multifactorial role of these metabolites on the host immunological phenotype. SCFA have been shown to modulate several cell signaling pathways in immune cells11,12,13, indicating that intestinal microbiota shape the immune system through their metabolites, and hence that SCFA are key mediators for the host-microbe mutualism. Indeed, the exacerbated inflammatory reactions observed in germ-free mouse models of disease are likely to relate in part to the absence of SCFA in the gut, blood, or tissues14,15. SCFA exert their effects through G-protein-coupled receptors (GPCRs). The major GPCRs activated by SCFA are GPR43 (FFAR2) and GPR41 (FFAR3), and GPR109A (HCAR2) for both murine and human immune cells16,17,18,19,20,21. However, the expression pattern of SCFA receptors in human DC has been poorly investigated, although expression of GPR41 and GPR43 mRNA in human DC has been described16,18. DC are professional antigen-presenting cells within the immune system and once activated they play a pivotal role in attracting and priming T-cells. Recently, propionate was shown to affect mouse dendritic cells (DC) and macrophage biology in the bone marrow and affect T helper 2 (Th2) cell responses in the airway22 confirming the important role of SCFA on the mouse immune system. However, little is known about the effect of SCFA on human DC. The experimental use of human primary DC is limited by their scarcity in peripheral blood (<1% of peripheral blood mononuclear cells (PBMC)), so to circumvent this, monocyte-derived DC in vitro are commonly employed as a pragmatic model23,24. The aim of this study was to investigate the gene transcription modulation by Affymetrix GeneChip and potential pathways in human immature and mature human monocyte-derived DC after exposure to acetate, butyrate, or propionate. The results revealed distinct transcriptional responses elicited by these bacterial metabolites indicating that butyrate and propionate exerts important immunomodulatory roles by down-regulating genes involved in inflammation and immune cell trafficking. RESULTS SCFA receptor expression by human monocyte-derived DC To determine the expression pattern of SCFA receptors on human monocyte-derived DC, we performed qPCR assays for the main SCFA receptors genes such as GPR43, GPR41, and GPR109A. MCF-7 cells were used as positive control as they have previously been reported to express both GPR43 and GPR4125. As shown in Fig. 1a we found that human monocyte-derived DC expresses GPR43 and GPR41 mRNA at lower and higher level, respectively, compared to the positive control cell line MCF-7. In addition, we observed very high expression levels of GPR109A mRNA in human monocyte-derived DC. Furthermore, we investigated the surface expression of GPR41 and GPR109A on human monocyte-derived DC by flow cytometry. As shown in Fig. 1b, we used cells from three different donors, (each donor represented by different shades of grey), to confirm that both receptors are expressed, albeit we observed that surface proteins expression of GPR41 was higher than GPR109A. [Figure: Expression of SCFA receptors by human monocyte-derived DC and primary CD141 + and CD1c + DC.(a) qPCR for SCFAs receptors on monocyte-derived DC compared to MCF-7 cell line as internal control. Shown are the averages ± standard deviations (SD) (n = 3). (b) Flow cytometry analysis of GPR41 and GPR109A surface expression on monocyte-derived DC and (c) primary CD141 + and CD1c + DC. Mean fluorescence intensity (MFI) averages ± standard deviations (SD) (n = 3) are reported below each histogram. Gates for GPR41- or GPR190A-positive cells in both figures (b,c) has been placed according to their respective isotype control. The different shades of grey represent cells from three different donors used for the experiments.] Furthermore, we examined the expression of SCFA receptors on primary human CD1c+ and CD141 + DC by flow cytometry. We found that both subsets of DC express GPR41 and GPR109 on the surface of cells from three different donors (Fig. 1c, each donor represented by a different shade of grey). Taken together, this indicates that human monocyte-derived DC, like primary human CD1c+ and CD141+ DC, has the ability to respond to SCFA through GPR41 and GPR109A. DC exposure to SCFA and impact on maturation markers Monocytes isolated from three different healthy donors were used to generate both im-DC and m-DC. Then im-DC were treated with 1 mM (physiological concentration) of sodium acetate (im-DC_A), sodium butyrate (im-DC_B),